ANTI-HBc

(redirected from Antibody to Hepatitis B Core Antigen)
AcronymDefinition
ANTI-HBcAntibody to Hepatitis B Core Antigen (blood testing)
References in periodicals archive ?
Patient samples were tested for 1) human immunodeficiency virus, 2) hepatitis C virus (HCV) antibody with HCV RNA testing of all positives, 3) HBV DNA, 4) hepatitis B surface antigen, 5) total and immunoglobulin M antibody to hepatitis B core antigen, and 6) antibody to hepatitis B surface antigen.
of participants Age (yrs) with anti-HBs (%) with distribution positivity anti-HBc positivity 20 - 29 10 (11.2) 0 30 - 39 21 (23.6) 3 (15) 40 - 49 37 (41.6) 11 (55) 50 - 59 16 (18) 2 (10) >60 5 (5.6) 1 (5) Anti-HBs = antibody to hepatitis B surface antigen; anti-HBc = antibody to hepatitis B core antigen..
31, the FDA granted Pre-market Approval (PMA) to Roche for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay, for use on the cobas e 601 analyzer.
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Calabrese likes to get a hepatitis B surface antigen (HB-sAg), antibody to hepatitis B surface antigen (anti-HBs), and antibody to hepatitis B core antigen (anti-HBc).
Micronesian adolescents who had received three doses of recombinant hepatitis B vaccine (at birth, 2 months, and 6 months of age) and who had tested negative for antibody to hepatitis B core antigen (anti-HBc) 2 years after the primary vaccination were followed for 15 years after the primary vaccination.
Immulite 2000 anti-HBc IgM assay: IgM antibody to hepatitis B core antigen. DPC Immulite 2000 assay instructions.
As in previous recommendations, the CDC advises using tests for hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti-HBs), and antibody to hepatitis B core antigen (anti-HBc) to evaluate persons for current or past HBV infection.
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.
A susceptible patient was defined as a hemodialysis patient who was negative for HBsAg, antibody to HBsAg (anti-HBs), and antibody to hepatitis B core antigen (anti-HBc).
Full browser ?